Akero Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Akero Therapeutics's balance sheet done over the years? Its assets were worth $580,271,000 last year, which is more than in the previous period. 8% of Akero Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $44,965,000, which means an increase by 50% compared compared to last year.

Debt to Assets

Akero Therapeutics, Inc. (NASDAQ:AKRO): Debt to assets
2017 658000 5.22M 793.62%
2018 77151000 127.07M 164.7%
2019 138118000 9.39M 6.8%
2020 273339000 14.62M 5.35%
2021 195548000 26.43M 13.52%
2022 356570000 30.00M 8.42%
2023 580271000 44.96M 7.75%

AKRO Balance Sheet (2017 – 2023)

2023 2022 2021 2020 2019 2018 2017
Assets
Current assets:
Cash and cash equivalents
234.20M249.77M150.48M187.24M136.4M75.97M598K
Short term investments
315.80M101.67M37.77M81.14M71.61M00
Net receivables
0000000
Inventory
0000000
Other current assets
9.95M3.72M5.32M2.95M1.64M1.15M80K
Total current assets
559.96M355.17M193.58M271.34M138.04M77.13M638K
Non-current assets:
Property, Plant and Equipment
1.02M1.28M1.54M1.79M000
Goodwill
0000000
Intangible assets
0000000
Long term investments
19.28M0040K40K020K
Other non-current assets
0108K417K161K29K20K0
Total non-current assets
20.30M1.39M1.96M1.99M69K20K20K
Total assets
580.27M356.57M195.54M273.33M138.11M77.15M658K
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
0000000
Short term debt
522K325K205K294K000
Total current liabilities
19.12M19.08M25.12M13.11M9.36M2.34M222K
Non-current liabilities:
Long term debt
25.78M10.62M1.31M1.51M000
Deferred tax
0000000
Other non-current liabilities
54K305K0023K124.72M5M
Total non-current liabilities
25.83M10.92M1.31M1.51M23K124.72M5M
Total liabilities
44.96M30.00M26.43M14.62M9.39M127.07M5.22M
Data sourceData sourceData sourceData sourceData source